Dan managed Cancer Research UK’s research and charity policy team which works across a range of issues to ensure that Government continues to support medical research. Before coming to Cancer Research UK, Dan previously worked for the biotech and stem cell industry following a brief stint interning for an MP in Leeds.
Our new report, Every Patient a Research Patient? looks at how well the NHS is performing at offering cancer patients the opportunity to take part in research.
We discuss a new report that looks at the wider economic impact of cancer research.
A new £4.5 million Government funding boost will improve the way research is approved in the NHS. But what does it mean for patients?
We want to understand cancer and cure it. To do this we not only need the best scientific minds doing…
Last year was a breakthrough year for radiotherapy. We have been talking about radiotherapy’s importance, and the need for better…
This afternoon,we waited with bated breath as Chancellor George Osborne stood up to outline exactly how much Government departments would…
These are difficult times for the economy. Next month, the Government is set to announce the results of its recent…
Clinical trials are vital – they’re how we know which treatments work, how best to use them, and what the…
As the NHS is going through a period of change that “can be seen from space” Cancer Research UK and…
Without clinical trials, there would be no new cancer treatments. And there are few better places to set up a…